Log In
Print
BCIQ
Print
Print this Print this
 

Abstral, fentanyl (Rapinyl) (EN 3267, KW-2246)

Also known as: OX20

  Manage Alerts
Collapse Summary General Information
Company Orexo AB
DescriptionSublingual mucoadhesive fentanyl
Molecular Target Opioid receptor (OPR)
Mechanism of ActionOpioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat breakthrough cancer pain; Treat cancer pain
Regulatory Designation
Partner Endo International plc; Galena Biopharma Inc.; Hisamitsu Pharmaceutical Co. Inc.; Kyowa Hakko Kirin Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

6

$1,604.8M

$37.9M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today